Amicus Therapeutics CEO Campbell Bradley L Buys and Sells 14,587 Shares.

Amicus Therapeutics, Inc. has announced that Campbell Bradley L, a member of the company's board of directors, president, and chief executive officer, has engaged in a transaction involving the purchase and sale of shares. On December 1, 2025, Mr. Bradley acquired 14,587 shares at a price of $9.03 per share, and subsequently sold the same number of shares at a price of $10.01 per share on the same day.